Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Discovery: Overview01:26

Drug Discovery: Overview

12.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.2K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.8K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.8K
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

4.0K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
4.0K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

55
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
55

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Long-Term Mechanical Complications After Lumbar Fusion in Patients Receiving Tirzepatide vs Other GLP-1 Receptor Agonists.

Spine·2026
Same author

Recent neurodevelopmental outcomes of extremely and very preterm infants: A multicenter retrospective cohort study.

Early human development·2026
Same author

Feasibility of NIV-NAVA as a primary respiratory support and its clinical impacts in a targeted group of preterm infants: protocol for a prospective observational study.

BMJ open·2026
Same author

Long-Term Risk of Subsequent Cervical Fusion After Endoscopic Versus Open Cervical Decompression.

Global spine journal·2026
Same author

Artificial intelligence and nursing science: Opportunities, challenges, implications, and guidelines.

Nursing outlook·2026
Same author

Meaning and Influencing Factors of a Good Death for Community-Dwelling Individuals With Dementia: An Integrative Review.

International journal of older people nursing·2026
Same journal

Correction: Komatsu et al. Three-Dimensional Visualization and Detection of the Pulmonary Venous-Left Atrium Connection Using Artificial Intelligence in Fetal Cardiac Ultrasound Screening. <i>Bioengineering</i> 2026, <i>13</i>, 100.

Bioengineering (Basel, Switzerland)·2026
Same journal

Comparison of CO<sub>2</sub> Laser and Microdebrider in the Surgical Treatment of Pediatric Recurrent Respiratory Papillomatosis: A Retrospective Analysis.

Bioengineering (Basel, Switzerland)·2026
Same journal

Toward More Translational Tumor Models: Breast dECM-Based 3D Systems Capture Native Microenvironmental Cues.

Bioengineering (Basel, Switzerland)·2026
Same journal

Postural Stability Changes During the 4 Phases of the Half Squat: Kinematics Profile of the Center of Pressure and Center of Mass in High-Performance Weightlifters-A Pilot Study.

Bioengineering (Basel, Switzerland)·2026
Same journal

Definite Implant Position as Novel Readout for Effectiveness of Ridge Preservation Indicates to Beneficial Effect of Combined Treatment with Platelet-Rich Fibrin (PRF) and Xenogenic Biomaterial in Bone Regeneration.

Bioengineering (Basel, Switzerland)·2026
Same journal

Trueness and Precision of Intraoral Scanners for 3D-Printed Orthodontic Models with Attachments: An In Vitro Comparative Study.

Bioengineering (Basel, Switzerland)·2026
查看所有相关文章

相关实验视频

Updated: Mar 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.3K

TrialSieve:一个全面的生物医学信息提取框架用于PICO,元分析和药物重用.

David Kartchner1, Haydn Turner1, Christophe Ye1

  • 1Laboratory for Pathology Dynamics, Georgia Institute of Technology, Emory University School of Medicine, Atlanta, GA 30332, USA.

Bioengineering (Basel, Switzerland)
|May 28, 2025
PubMed
概括
此摘要是机器生成的。

TrialSieve 增强了生物医学信息提取功能,用于临床元分析和药物重新用途. 在其数据上训练的自动NLP模型可以匹配或超过人类在注释任务中的表现.

关键词:
人工智能的人工智能是人工智能.生物修复的生物修复生物医学信息提取 提取生物医学信息生物医学文献注释注释生物医学文献的图表表格式大型语言模型命名实体的认可 命名实体的认可自然语言处理自然语言处理.文本采矿 文本采矿是什么

更多相关视频

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

1.1K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K

相关实验视频

Last Updated: Mar 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.3K
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

1.1K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K

科学领域:

  • 生物医学信息学 生物医学信息学
  • 自然语言处理自然语言处理.
  • 临床研究 临床研究

背景情况:

  • 传统的PICO (患者,干预,比较,结果) 方法缺乏临床结果的定量比较能力.
  • 生物医学信息提取对于元分析和药物再利用至关重要,但面临着数据复杂性的挑战.
  • 现有的注释框架可能无法完全捕捉全面系统审查所需的细微差别.

研究的目的:

  • 介绍TrialSieve,一个用于生物医学信息提取的新框架.
  • 通过改进数据注释和比较,加强临床元分析和药物重定位.
  • 使用TrialSieve数据集评估各种NLP模型和大型语言模型 (LLM) 的性能.

主要方法:

  • 开发了TrialSieve,结合了分层的,基于治疗组的图表来扩展PICO.
  • 1609个PubMed摘要有20个类别,导致170,557个注释和52,638个跨度.
  • 在TrialSieve数据集上评估NLP模型 (BioLinkBERT, BioBERT, KRISSBERT, PubMedBERT) 和GPT-4o用于实体标签.
  • 进行了注释器用户研究 (n=39),以评估TrialSieve注释方法的效率和准确性.

主要成果:

  • 在生物医学实体标签中,BioLinkBERT实现了最高的准确性 (0.875) 和回忆 (0.679).
  • PubMedBERT显示了最好的精度 (0.614) 和F1得分 (0.639).
  • 在不完美注释的数据上训练的NLP模型匹配或超过了人类的性能,表明自动化的可行性.
  • 基于TrialSieve树的方法显著提高了注释器的效率和准确性 (p < 0.05).

结论:

  • TrialSieve为自动化生物医学信息提取提供了一个坚实的基础.
  • 该框架为临床元分析和药物重新用途提供了更全面和定量比较的便利.
  • 使用NLP模型自动提取信息是可行的,即使有噪音,人类注释的数据集.